The present invention provides substituted pyrazine derivatives of Formula (I), that are CRF1 receptor antagonists, including human CRF1 receptors. This invention also relates to use of compounds of the invention for treating a disorder or condition, the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as CNS disorders, particularly anxiety-related disorders and mood disorders.
本发明提供了式(I)的取代
吡嗪衍
生物,其为CRF1受体拮抗剂,包括人类CRF1受体。本发明还涉及利用本发明的化合物治疗疾病或症状,其治疗可以通过拮抗CRF受体来实现或促进,例如中枢神经系统疾病,特别是与焦虑有关的疾病和情绪障碍。